Yuichiro Tsukada, M., Norio Saito, M., Yuji Nishizawa, M., Riki Ohno, M., Fumihiko Fujita, M., Keiji Koda, M., . . . Masaaki Ito, M. (2025). Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial. Wolters Kluwer Health.
Chicago Style (17th ed.) CitationYuichiro Tsukada, MD, et al. Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial. Wolters Kluwer Health, 2025.
MLA (9th ed.) CitationYuichiro Tsukada, MD, et al. Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial. Wolters Kluwer Health, 2025.
Warning: These citations may not always be 100% accurate.